August 10, 2021

Dermavant Announces FDA Acceptance for Filing of N ...

Read More

June 3, 2021

Dermavant Submits New Drug Application (NDA) to FD ...

Read More

April 16, 2021

Dermavant Announces Tapinarof Data Presentations a ...

Read More

January 15, 2020

Dermavant Enters into Exclusive License Agreement ...

Read More

June 5, 2019

Dermavant Sciences Announces First Patient Dosed i ...

Read More

March 27, 2019

Dermavant Sciences Announces Appointment of Cyril ...

Read More

February 21, 2019

Dermavant Sciences to Present Data on Tapinarof fo ...

Read More

January 2, 2019

Dermavant Sciences Announces Appointment of Dr. Ph ...

Read More

October 11, 2018

Dermavant Sciences to Present Tapinarof Phase 2B D ...

Read More

September 4, 2018

Dermavant Announces Changes to Leadership and Boar ...

Read More

August 21, 2018

Dermavant Sciences Announces Closing of Transactio ...

Read More

July 12, 2018

Roivant subsidiary Dermavant Sciences signs agreem ...

Read More